Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: An update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study

International Review of Psychiatry

Volumn 25, Issue 6, 2013, Pages 699-710

  Ellis, Kathryn A ^a,b,c   Rainey Smith, Stephanie R ^d,e   Rembach, Alan ^b   Macaulay, S Lance ^f   Villemagne, Victor L ^b,g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^d HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^e EDITH COWAN UNIVERSITY   (Australia)

^f CSIRO   (Australia)

^g AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; CERULOPLASMIN; COPPER; HOMOCYSTEINE;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; BRAIN ATROPHY; BRAIN FUNCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL DEMENTIA RATING; COGNITION; DEGENERATIVE DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIET; EARLY DIAGNOSIS; ELISA KIT; EPISODIC MEMORY; GENOTYPE; HEALTH CARE DELIVERY; HIPPOCAMPUS; HUMAN; LABORATORY TEST; LIFESTYLE; LONGITUDINAL STUDY; MEDITERRANEAN DIET; MILD COGNITIVE IMPAIRMENT; MULTIDISCIPLINARY APPROACH; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TEAMWORK;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; HUMANS; LONGITUDINAL STUDIES; NEUROIMAGING;

EID: 84892706897     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.870136     Document Type: Article

References (95)

1. Abbott, R.D., White, L.R., Ross, G.W., Masaki, K.H., Curb, J.D. & Petrovitch, H. (2004). Walking and dementia in physically capable elderly men. Journal of the American Medical Association, 292, 1447-1453.
2. Acosta, O., Fripp, J., Doré, V., Bourgeat, P., Favreau, J.M., Chételat, G.,... Salvado, O. (2012). Cortical surface mapping using topology correction, partial flattening and 3D shape context- based non-rigid registration for use in quantifying atrophy in Alzheimer's disease. Journal of Neuroscience Methods, 205, 96-109.
3. AD International. (2010). The Global Economic Impact of Dementia. London: Alzheimer's Disease International.
4. Adlard, P.A., Perreau, V.M., Pop, V. & Cotman, C.W. (2005). Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. Journal of Neuroscience, 25, 4217-4221.
5. Ancelin, M.L., Artero, S., Portet, F., Dupuy, A.M., Touchon, J. & Ritchie, K. (2006). Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. British Medical Journal, 332, 455-459.
6. Andrews, K.A., Modat, M., Macdonald, K.E., Yeatman, T., Cardoso, M.J., Leung, K.K.,... Schott, J.M. (2013). Atrophy rates in asymptomatic amyloidosis: Implications for Alzheimer prevention trials. PLOS ONE, 8. doi: 10.1371/journal.pone. 0058816
7. Bacskai, B.J., Frosch, M.P., Freeman, S.H., Raymond, S.B., Augustinack, J.C., Johnson, K.A.,... Growdon, J.H. (2007). Molecular imaging with Pittsburgh Compound B confirmed at autopsy: A case report. Archives of Neurology, 64, 431-434.
8. Bottiggi, K.A., Salazar, J.C., Yu, L., Caban-Holt, A.M., Ryan, M., Mendiondo, M.S. & Schmitt, F.A. (2006). Long-term cognitive impact of anticholinergic medications in older adults. American Journal of Geriatric Psychiatry, 14, 980-984.
9. Bourgeat, P., Chételat, G., Villemagne, V.L., Fripp, J., Raniga, P., Pike, K.,... Salvado, O. (2010). Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology, 74, 121-127.
10. Bowen, R.L., Isley, J.P. & Atkinson, R.L. (2000). An association of elevated serum gonadotropin concentrations and Alzheimer disease Journal of Neuroendocrinology, 12, 351-354.
11. Bowen, R.L., Verdile, G., Liu, T., Parlow, A.F., Perry, G., Smith, M.A.,... Atwood, C.S. (2004). Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. Journal of Biological Chemistry, 279, 20539-20545.
12. Brown, B.M., Peiffer, J.J., Sohrabi, H.R., Mondal, A., Gupta, V.B., Rainey-Smith, S.R.,... Martins, R.N. (2012a). Intense physical activity is associated with cognitive performance in the elderly. Translational Psychiatry, 2, e191.
13. Brown, B.M., Peiffer, J.J., Taddei, K., Lui, J.K., Laws, S.M., Gupta, V.B.,... Martins, R.N. (2012b). Physical activity and amyloid-beta plasma and brain levels: Results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Molecular Psychiatry, 18, 875-881.
14. Buckley, R., Saling, M.M., Ames, D., Rowe, C.C., Lautenschlager, N.T., Macaulay, S.L.,... Ellis, K.A. (2013). Factors affecting subjective memory complaints in the AIBL aging study: Biomarkers, memory, affect, and age. International Psychogeriatrics, 25, 1307-1315.
15. Burnham, S.C., Faux, N.G., Wilson, W., Laws, S.M., Ames, D., Bedo, J.,... Villemagne, V.L. (2013). A blood-based predictor for neocortical Abeta burden in Alzheimer's disease: Results from the AIBL study. Molecular Psychiatry. doi: 10.1038/mp.2013.40
16. Cancelli, I. (2010). Anticholinergic drugs increase the risk of cognitive decline and dementia in older people. Evidence-Based Mental Health, 13, 44.
17. Cancelli, I., Beltrame, M., Gigli, G.L. & Valente, M. (2009). Drugs with anticholinergic properties: Cognitive and neuropsychiatric side-effects in elderly patients. Neurological Sciences, 30, 87-92.
18. Cancelli, I., Gigli, G.L., Piani, A., Zanchettin, B., Janes, F., Rinaldi, A. & Valente, M. (2008). Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: A population-based study. Journal of Clinical Psychopharmacology, 28 (6), 654-659.
19. Capitani, E., Cazzaniga, R., Francescani, A. & Spinnler, H. (2004). Cognitive deterioration in Alzheimer's disease: Is the early course predictive of the later stages Neurological Sciences, 25 (4), 198-204.
20. Chételat, G., Villemagne, V.L., Bourgeat, P., Pike, K.E., Jones, G., Ames, D.,... Rowe, C.C. (2010a). Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Annals of Neurology, 67, 317-324.
21. Chételat, G., Villemagne, V.L., Pike, K.E., Baron, J.C., Bourgeat, P., Jones, G.,... Rowe, C.C. (2010b). Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain, 133, 3349-3358.
22. Chételat, G., Villemagne, V.L., Pike, K.E., Ellis, K.A., Bourgeat, P., Jones, G.,... Rowe, C.C. (2011). Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain, 134 (3), 798-807.
23. Chételat, G., Villemagne, V.L., Villain, N., Jones, G., Ellis, K.A., Ames, D.,... Rowe, C.C. (2012). Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition. Neurology, 78, 477-484.
24. Chiu, H.F. & Brodaty, H. (2013). Arguments against the biomarkerdriven diagnosis of AD. International Psychogeriatrics, 25, 177-181.
25. Clarke, R., Smith, A.D., Jobst, K.A., Refsum, H., Sutton, L. & Ueland, P.M. (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of Neurology, 55, 1449-1455.
26. Crook, T.H. III, Feher, E.P. & Larrabee, G.J. (1992). Assessment of memory complaint in age-associated memory impairment: The MAC-Q. International Psychogeriatrics, 4, 165-176.
27. Doecke, J.D., Laws, S.M., Faux, N.G., Wilson, W., Burnham, S.C., Lam, C.P.,... Martins, R.N. (2012). Blood-based protein biomarkers for diagnosis of Alzheimer disease. Archives of Neurology, 69 (10), 1318-1325.
28. Doody, R.S., Massman, P. & Dunn, J.K. (2001). A method for estimating progression rates in Alzheimer disease. Archives of Neurology, 58, 449-454.
29. Doré, V., Villemagne, V.L., Bourgeat, P., Fripp, J., Acosta, O., Chételat, G.,... Rowe, C.C. (2013). Cross-sectional and longitudinal analysis of the relationship between A βdeposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Journal of the American Medical Association Neurology, 70 (7), 903-911.
30. Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A.,... Weinberger, D.R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257-269.
31. Ellis, K.A., Bush, A.I., Darby, D., De Fazio, D., Foster, J., Hudson, P.,... Ames, D. (2009). The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672-687.
32. Ellis, K.A., Lim, Y.Y., Harrington, K., Ames, D., Bush, A.I., Darby, D.,... Maruff, P. (2013). Decline in cognitive function over 18 months in healthy older adults with high amyloid-beta. Journal of Alzheimer's Disease, 34, 861-871.
33. Erickson, K.I., Voss, M.W., Prakash, R.S., Basak, C., Szabo, A., Chaddock, L.,... Kramer, A.F. (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences of the United States of America, 108, 3017-3022.
34. Fagan, A.M., Mintun, M.A., Mach, R.H., Lee, S.Y., Dence, C.S., Shah, A.R.,... Holtzman, D.M. (2006). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Annals of Neurology, 59, 512-519.
35. Fahnestock, M. (2011). Brain-derived neurotrophic factor: The link between amyloid- βand memory loss. Future Neurology, 6, 627-639.
36. Faux, N.G., Ellis, K.A., Porter, L., Fowler, C.J., Laws, S.M., Martins, R.N.,... Bush, A.I. (2011). Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: Baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. Journal of Alzheimer's Disease, 27, 909-922.
37. Feart, C., Samieri, C., Rondeau, V., Amieva, H., Portet, F., Dartigues, J.F.,... Barberger-Gateau, P. (2009). Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. Journal of the American Medical Association, 302, 638-648.
38. Flicker, C., Ferris, S.H. & Serby, M. (1992). Hypersensitivity to scopolamine in the elderly. Psychopharmacology, 107, 437-441.
39. Fripp, J., Bourgeat, P., Acosta, O., Raniga, P., Modat, M., Pike, K.E.,... Ourselin, S. (2008a). Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging. NeuroImage, 43, 430-439.
40. Fripp, J., Bourgeat, P., Raniga, P., Acosta, O., Villemagne, V., Jones, G.,... Salvado, O. (2008b). MR-less high dimensional spatial normalization of 11C PiB PET images on a population of elderly, mild cognitive impaired and Alzheimer disease patients. Medical Image Computing and Computer Assisted Intervention, 11, 442-449.
41. Gardener, S., Gu, Y., Rainey-Smith, S.R., Keogh, J.B., Clifton, P.M., Mathieson, S.L.,... Martins, R.N. (2012). Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Translational Psychiatry 2, e164.
42. Garzon, D.J. & Fahnestock, M. (2007). Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. Journal of Neuroscience, 27, 2628-2635.
43. Gupta, V.B., Laws, S.M., Villemagne, V.L., Ames, D., Bush, A.I., Ellis, K.A.,... Martins, R.N. (2011). Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging. Neurology, 76, 1091-1098.
44. Han, L., Agostini, J.V. & Allore, H.G. (2008). Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. Journal of the American Geriatrics Society, 56, 2203-2210.
45. Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F. & Weinberger, D.R. (2003). Brainderived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience, 23, 6690-6694.
46. Holland, J., Bandelow, S. & Hogervorst, E. (2011). Testosterone levels and cognition in elderly men: A review. Maturitas, 69, 322-337.
47. Ikonomovic, M.D., Klunk, W.E., Abrahamson, E.E., Mathis, C.A., Price, J.C., Tsopelas, N.D.,... DeKosky, S.T. (2008). Postmortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain, 131 (6), 1630-1645.
48. Kalmijn, S., Launer, L.J., Lindemans, J., Bots, M.L., Hofman, A. & Breteler, M.M. (1999). Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. American Journal of Epidemiology, 150, 283-289.
49. Kant, A.K. (1996). Indexes of overall diet quality: A review. Journal of the American Dietetic Association, 96, 785-791.
50. Klunk, W.E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D.P.,... Langstrom, B. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology, 55, 306-319.
51. Larson, E.B., Wang, L., Bowen, J.D., McCormick, W.C., Teri, L., Crane, P. & Kukull, W. (2006). Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Annals of Internal Medicine, 144, 73-81.
52. Lautenschlager, N.T., Cox, K.L., Flicker, L., Foster, J.K., van Bockxmeer, F.M., Xiao, J.,... Almeida, O.P. (2008). Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. Journal of the American Medical Association, 300, 1027-1037.
53. Le Couteur, D.G., Doust, J., Creasey, H. & Brayne, C. (2013). Political drive to screen for pre-dementia: Not evidence based and ignores the harms of diagnosis. BMJ, 347, f5125.
54. Leinonen, V., Alafuzoff, I., Aalto, S., Suotunen, T., Savolainen, S., Nagren, K.,... Rinne, J.O. (2008). Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Archives of Neurology, 65, 1304-1309.
55. Lim, Y.Y., Ellis, K.A., Ames, D., Darby, D., Harrington, K., Martins, R.N.,... Maruff, P. (2012a). Abeta amyloid, cognition, and APOE genotype in healthy older adults. Alzheimer's and Dementia. doi: 10.1016/j.jalz.2012.07.004
56. Lim, Y.Y., Ellis, K.A., Harrington, K., Kamer, A., Pietrzak, R.H., Bush, A.I.,... Maruff, P. (2013a). Cognitive consequences of high Abeta amyloid in mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer's disease. Neuropsychology, 27, 322-332.
57. Lim, Y.Y., Ellis, K.A., Harrington, K., Pietrzak, R.H., Gale, J., Ames, D.,... Maruff, P. (2013b). Cognitive decline in adults with amnestic mild cognitive impairment and high amyloidbeta: Prodromal Alzheimer's disease Journal of Alzheimer's Disease, 33, 1167-1176.
58. Lim, Y.Y., Ellis, K.A., Pietrzak, R.H., Ames, D., Darby, D., Harrington, K.,... Maruff, P. (2012b). Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology, 79, 1645-1652.
59. Lim, Y.Y., Villemagne, V.L., Laws, S.M., Ames, D., Pietrzak, R.H., Ellis, K.A.,... Maruff, P. (2013c). BDNF Val66Met, Abeta amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging, 34 (11), 2457-2464.
60. Lui, J.K., Laws, S.M., Li, Q.X., Villemagne, V.L., Ames, D., Brown, B.,... Group, A.R. (2010). Plasma amyloid-beta as a biomarker in Alzheimer's disease: The AIBL study of aging. Journal of Alzheimer's Disease, 20, 1233-1242.
61. Mielke, M.M., Leoutsakos, J.M., Corcoran, C.D., Green, R.C., Norton, M.C., Welsh-Bohmer, K.A.,... Lyketsos, C.G. (2012). Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression. Alzheimer's and Dementia, 8, 180-187.
62. Minati, L., Edginton, T., Bruzzone, M.G. & Giaccone, G. (2009). Current concepts in Alzheimer's disease: A multidisciplinary review. American Journal of Alzheimer's Disease and Other Dementias, 24, 95-121.
63. Morris, J.C., Aisen, P.S., Bateman, R.J., Benzinger, T.L., Cairns, N.J., Fagan, A.M.,... Buckles, V.D. (2012). Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation, 2, 975-984.
64. Nordberg, A., Carter, S.F., Rinne, J., Drzezga, A., Brooks, D.J., Vandenberghe, R.,... Herholz, K. (2013). A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging, 40, 104-114.
65. Ortega, R.M., Requejo, A.M., Andres, P., Lopez-Sobaler, A.M., Quintas, M.E., Redondo, M.R.,... Rivas, T. (1997). Dietary intake and cognitive function in a group of elderly people. American Journal of Clinical Nutrition, 66, 803-809.
66. Oulhaj, A., Refsum, H., Beaumont, H., Williams, J., King, E., Jacoby, R. & Smith, A.D. (2010). Homocysteine as a predictor of cognitive decline in Alzheimer's disease. International Journal of Geriatric Psychiatry, 25, 82-90.
67. Peng, S., Wuu, J., Mufson, E.J. & Fahnestock, M. (2005). Precursor form of brain-derived neurotrophic factor and mature brainderived neurotrophic factor are decreased in the preclinical stages of Alzheimer's disease. Journal of Neurochemistry, 93, 1412-1421.
68. Petersen, R.C., Roberts, R.O., Knopman, D.S., Boeve, B.F., Geda, Y.E., Ivnik, R.J.,... Jack, C.R., Jr. (2009). Mild cognitive impairment: ten years later. Archives of Neurology, 66, 1447-1455.
69. Pike, K.E., Ellis, K.A., Villemagne, V.L., Good, N., Chételat, G., Ames, D.,... Rowe, C.C. (2011). Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study. Neuropsychologia, 49, 2384-2390.
70. Rabinovici, G.D., Furst, A.J., O'Neil, J.P., Racine, C.A., Mormino, E.C., Baker, S.L.,... Jagust, W.J. (2007). 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology, 68, 1205-1212.
71. Raniga, P., Bourgeat, P., Fripp, J., Acosta, O., Villemagne, V.L., Rowe, C.,... Ourselin, S. (2008). Automated (11)C-PiB standardized uptake value ratio. Academic Radiology, 15, 1376-1389.
72. Reid, L.M. & Maclullich, A.M. (2006). Subjective memory complaints and cognitive impairment in older people. Dementia and Geriatric Cognitive Disorders, 22, 471-485.
73. Reiman, E.M., Langbaum, J.B. & Tariot, P.N. (2010). Alzheimer's prevention initiative: A proposal to evaluate presymptomatic treatments as quickly as possible. Biomarkers in Medicine, 4, 3-14.
74. Rembach, A., Doecke, J.D., Roberts, B.R., Watt, A.D., Faux, N.G., Volitakis, I.,... Bush, A.I. (2012). Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's Disease. Journal of Alzheimer's Disease, 34 (1), 171-182.
75. Rembach, A., Faux, N.G., Watt, A.D., Pertile, K.K., Rumble, R.L., Trounson, B.O.,... Masters, C.L. (2013). Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's and Dementia. doi: 10.1016/j.jalz.2012.12.006
76. Riggs, K.M., Spiro, A. III, Tucker, K. & Rush, D. (1996). Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition, 63, 306-314.
77. Roberts, J.L., Clare, L. & Woods, R.T. (2009). Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: A systematic review. Dementia and Geriatric Cognitive Disorders, 28, 95-109.
78. Rowe, C.C., Ellis, K.A., Rimajova, M., Bourgeat, P., Pike, K.E., Jones, G.,... Villemagne, V.L. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging, 31, 1275-1283.
79. Rowe, C.C., Ng, S., Ackermann, U., Gong, S.J., Pike, K., Savage, G.,... Villemagne, V.L. (2007). Imaging beta-amyloid burden in aging and dementia. Neurology, 68, 1718-1725.
80. Rowe, C.C. & Villemagne, V.L. (2011). Brain amyloid imaging. Journal of Nuclear Medicine, 52, 1733-1740.
81. Scarmeas, N., Stern, Y., Tang, M.X., Mayeux, R. & Luchsinger, J.A. (2006). Mediterranean diet and risk for Alzheimer's disease. Annals of Neurology, 59, 912-921.
82. Schneider, L.S., Insel, P.S. & Weiner, M.W. (2011). Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of Neurology, 68, 58-66.
83. Sona, A., Zhang, P., Ames, D., Bush, A.I., Lautenschlager, N.T., Martins, R.N.,... Ellis, K.A. (2012). Predictors of rapid cognitive decline in Alzheimer's disease: Results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing. International Psychogeriatrics, 24, 197-204.
84. Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M.,... Phelps, C.H. (2011). Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia, 7, 280-292.
85. Squitti, R. (2012). Metals in alzheimer's disease: A systemic perspective. Frontiers in Bioscience, 17, 451-472.
86. Verdile, G., Laws, S.M., Henley, D., Ames, D., Bush, A.I., Ellis, K.A.,... Martins, R.N. (2012). Associations between gonadotropins, testosterone and beta amyloid in men at risk of Alzheimer's disease. Molecular Psychiatry. doi: 10.1038/mp.2012.147
87. Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K.A.,... Villemagne, V.L. (2012). Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: A voxelwise PiB-PET longitudinal study. Brain, 135 (7), 2126-2139.
88. Villemagne, V.L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K.A., Salvado, O.,... Masters, C.L. (2013). Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurology, 12 (4), 357-367.
89. Villemagne, V.L., Fodero-Tavoletti, M.T., Pike, K.E., Cappai, R., Masters, C.L. & Rowe, C.C. (2008). The ART of Loss: A βimaging in the evaluation of Alzheimer's disease and other dementias. Molecular Neurobiology, 38, 1-15.
90. Villemagne, V.L., Pike, K.E., Chételat, G., Ellis, K.A., Mulligan, R.S., Bourgeat, P.,... Rowe, C.C. (2011). Longitudinal assessment of A βand cognition in aging and Alzheimer disease. Annals of Neurology, 69, 181-192.
91. Wahjoepramono, E.J., Wijaya, L.K., Taddei, K., Bates, K.A., Howard, M., Martins, G.,... Martins, R.N. (2011). Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels. Neuroendocrinology, 94, 313-322.
92. Wahjoepramono, E.J., Wijaya, L.K., Taddei, K., Martins, G., Howard, M., de Ruyck, K.,... Martins, R.N. (2008). Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid- beta levels. Journal of Alzheimer's Disease, 15, 129-137.
93. Weiner, M.W., Veitch, D.P., Aisen, P.S., Beckett, L.A., Cairns, N.J., Green, R.C.,... Trojanowski, J.Q. (2012). The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer's and Dementia, 8, S1-68.
94. Yates, P.A., Sirisriro, R., Villemagne, V.L., Farquharson, S., Masters, C.L. & Rowe, C.C. (2011). Cerebral microhemorrhage and brain {beta}-amyloid in aging and Alzheimer disease. Neurology, 77, 48-54.
95. Zhou, L., Salvado, O., Doré, V., Bourgeat, P., Raniga, P., Villemagne, V. L.,... Fripp, J. (2012). MR-less surface-based amyloid estimation by subject-specific atlas selection and Bayesian fusion. Medical Image Computing and Computer Assisted Intervention, 15 (2), 220-227.